Clinical Trial: Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia

Study Status: Not yet recruiting
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia in Patients With Acute Leukemia Receiving Chemotherapy

Brief Summary: The purpose of this study is to evaluate the efficacy of ex vivo generated megakaryocytic progenitor cells (MPs) in prophylaxis and treatment of thrombocytopenia caused by chemotherapy in patients with acute leukemia (AL).